Phase 1 and 2 metabolic conversions and CYP enzymes Flashcards

1
Q

what are CYP enzymes

A
  • contain a heme group
  • membrane bound and associated with p450 reductase
  • large lipophilic cavity
  • no specificity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

p450 reductase role

A

NADPH binds to p450 and electrons are shuttled through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

6 phase 1 cyp mediated reactions

A

hydroxylation, dealkylation, dehydrogenation, epoxidation, epoxidation and dihydroxylation, monohydroxylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where can hydroxylation take place

A

at any carbon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of hydroxylation

A
  1. drug enters enzyme
  2. Fe5+ is very reactive and takes e- from =O to form fe4+
  3. radical formed, picks up OH from cyp 450
  4. Fe3+ is reformed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where can dealkylation take place

A

at any carbon next to a heteroatom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of dealkylation

A
  1. hydroxylation takes place
  2. OH bond of hydroxylation breaks, forming =O
  3. =O breaks the bond with the rest of the molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where can dehydrogenation take place

A

alkanes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of dehydrogenation

A
  1. radical formed by hydroxylation
  2. radical forms double bond
  3. elimination reaction reduces Fe4+ and removes one group
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

where can epoxidation take place

A

alkenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

epoxidation MOA

A
  1. double bond breaks to form a radical and breaks double bond in Fe5+=O
  2. radical reduces Fe4+ x2
  3. 2nd bond formed between radical and oxygen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where can epoxidation and dihydroxylation of aromatics take place

A

on aromatic rings with no substituents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of aromatic epoxidation and monohydroxylation

A
  1. pi bond forms covalent bond with O
  2. reduces Fe5+ and forms C radical
  3. radical binds to O to form epoxide and reduce Fe4+
  4. epoxide hydrolase breaks epoxide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

where can monohydroxylation take place

A

on aromatic rings with 2 unsubstituted carbons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

monohydroxylation MOA

A
  1. hydroxylation forms a radical
  2. radical reduces Fe4+ and forms bond to O
  3. Fe3+ breaks bond with O causing shift in benzene
  4. =O finds free H+ to form OH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

phase 1 non-cyp metabolism

A

epoxide hydrolase and ethanol metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

why are epoxides dangerous

A

covalently bond to N7 guanine in bases causing mutations and caner (apurinic DNA)

18
Q

epoxide hydrolase MOA

A

catalyses nucleophilic addition on presence of water (-O to 2x -OH)

19
Q

ethanol metabolism MOA

A

ethanol - alcohol dehydrogenase -> ethanal - aldehyde dehydrogenase -> ethanoic acid

20
Q

what is alcohol aversion therapy

A

disulfiram - inhibits aldehyde dehydrogenase leading to an increase in ethanal = increase in side effects

21
Q

other drugs that inhibit alcohol dehydrogenase

A

metronidazole, nitrofurantoin

22
Q

phase 2 metabolism reactions

A

glucuronidation, sulphation and glutathione conjugation

23
Q

what is glucuronidation

A

metabolite is conjugated with glucuronic acid

24
Q

MOA of glucuronidation

A

UDP + glucuronic acid cleaved by UDP-glucuronyl transferase and glucuronic acid is attached to an electron rich atom in the drug (N,O,S)

25
Q

what is sulphation

A

addition of SO3- to a drug, catalysed by sulfotransferase, requires PAPS

26
Q

what is PAPS

A

SO4 2- + ATP –> PAPS + ADD + PPI (3’phosphoadenosine-5’phosphosulfate)

27
Q

which molecules can undergo sulphation

A

usually phenols, sometimes alcohols

28
Q

what is glutathione conjugation

A

addition of glutathione to the molecule to neutralise it

29
Q

glutathione structure

A

gly-cys-glu

30
Q

MOA of glutathione conjugation

A

S in Cys is a strong nucleophile, with the help of glutathione-s-transferase, it is conjugated to the molecule

31
Q

factors affecting drug metabolism

A
  • drug metabolising enzyme polymorphisms
  • drug - drug interactions
  • age
  • gender
  • disease
32
Q

how do enzyme polymorphisms affect drug metabolism

A
  • SNIP - single nucleotide polymorphism can change the protein structure of the enzyme causing, no, increased or decreased enzyme activity
33
Q

how do drug-drug interactions affect drug metabolism

A

they can inhibit or induce the effects of other drugs

34
Q

how do drug-drug interactions inhibit metabolism

A
  • CYP450 inhibition!
  • by competitive/non-competitive inhibition, formation of inactive complexes or cyp450 destruction
35
Q

how do drug-drug interactions induce metabolism

A

induce the enzyme to work faster

36
Q

how does age affect drug metabolism

A

very young - not fully metabolically competent, virtually no phase 2 and limited phase 1
very old - decreased action, diminished enzyme induction and usually drug-drug interactions

37
Q

how does gender affect metabolism

A

first observed in rats, males metabolise faster - less significant in humans but thought to be due to sex hormones

38
Q

how does disease affect metabolism

A

endocrine, liver, infections can all alter metabolism

39
Q

what is alcoholic liver disease

A

prolonged alcohol exposure leading to inflammation - results in cirrhosis and fibrosis

40
Q

alcoholic liver disease effects on drug metabolism

A

acute exposure - inhibits
chronic exposure - induces
cirrhosis - inhibits

41
Q

what is cirrhosis

A

liver tissue is replaced by fibrous tissue resulting in metabolism inhibition (esp. CYP450)